Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution.

ABSTRACT: The success of targeted cancer therapy is limited by drug resistance that can result from tumor genetic heterogeneity. The current approach to address resistance typically involves initiating a new treatment after clinical/radiographic disease progression, ultimately resulting in futility in most patients. Towards a potential alternative solution, we developed a novel computational framework that uses human cancer profiling data to systematically identify dynamic, pre-emptive, and sometimes non-intuitive treatment strategies that can better control tumors in real-time. By studying lung adenocarcinoma clinical specimens and preclinical models, our computational analyses revealed that the best anti-cancer strategies addressed existing resistant subpopulations as they emerged dynamically duri

SUBMITTER: Jonsson VD 

PROVIDER: S-EPMC5347024 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature